Elon Musk Wins Reinstatement of Historic Tesla Pay Package After Delaware Supreme Court Ruling 
Italy Fines Apple €98.6 Million Over App Store Dominance 
Apple Opens iPhone to Alternative App Stores in Japan Under New Competition Law 
Niigata Set to Approve Restart of Japan’s Largest Nuclear Power Plant in Major Energy Shift 
Roche CEO Warns US Drug Price Deals Could Raise Costs of New Medicines in Switzerland 
Moore Threads Unveils New GPUs, Fuels Optimism Around China’s AI Chip Ambitions 
Trump Administration Reviews Nvidia H200 Chip Sales to China, Marking Major Shift in U.S. AI Export Policy 
Harris Associates Open to Revised Paramount Skydance Bid for Warner Bros Discovery 
JPMorgan’s Top Large-Cap Pharma Stocks to Watch in 2026 
Google and Apple Warn U.S. Visa Holders to Avoid International Travel Amid Lengthy Embassy Delays 
7-Eleven CEO Joe DePinto to Retire After Two Decades at the Helm 
AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study 
Maersk Vessel Successfully Transits Red Sea After Nearly Two Years Amid Ongoing Security Concerns 
Elliott Management Takes $1 Billion Stake in Lululemon, Pushes for Leadership Change 
Oracle Stock Surges After Hours on TikTok Deal Optimism and OpenAI Fundraising Buzz 
FDA Fast-Tracks Approval of Altria’s on! PLUS Nicotine Pouches Under New Pilot Program 
IRVING, Texas, Oct. 12, 2016 -- HMS Holdings Corp. (NASDAQ:HMSY) today announced that Alex Michael Azar II has been appointed to the HMS Board of Directors, effective October 11, 2016. Mr. Azar is President, Lilly USA, LLC, the largest affiliate of Eli Lilly & Company (NYSE:LLY). Prior to joining Lilly, Mr. Azar was the Deputy Secretary (2005-2007) and General Counsel (2001-2005) at the U.S. Department of Health & Human Services.
“Alex Azar brings an important blend of government and industry experience to our Board,” said Bill Lucia, Chairman and CEO. “He has an informed perspective on healthcare policy which will enrich our Board dialogue. In addition, Alex has extensive experience with big data in his current role at Lilly which is particularly relevant as we expand into the care management and data analytics field with our recent acquisition of Essette.”
Prior to his service at HHS, Mr. Azar was in private legal practice. He is a graduate of Dartmouth College and the Yale Law School, and was a Law Clerk to U.S. Supreme Court Justice Antonin Scalia.
“Expenditures in government programs - whether administered by CMS, state governments or health plans – are projected to continue growing at an unsustainable level. I look forward to joining the HMS Board and utilizing my public and private healthcare experience to contribute to its strategic discussion about ongoing efforts by HMS to develop and acquire solutions for payers that help bend the cost curve,” commented Mr. Azar.
About HMS
HMS Holdings Corp., through its subsidiaries, provides coordination of benefits, payment integrity and care management solutions for payers. The Company serves state Medicaid programs; health plans, including Medicaid managed care, Medicare Advantage and group and individual health lines of business; federal government health agencies, including the Centers for Medicare & Medicaid Services and the Veterans Health Administration; government and private employers; and other healthcare payers and sponsors, including child support agencies. As a result of the Company’s services, customers recover billions of dollars annually and save billions more through the prevention of improper payments.
Investor Contact: Dennis Oakes SVP, Investor Relations [email protected] 212-857-5786 Media Contact: Francesca Marraro VP, Marketing and Communications [email protected] 212-857-5442
